Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Azzak34on May 22, 2024 2:02pm
74 Views
Post# 36052393

RE:RE:RE:The evidence is clear

RE:RE:RE:The evidence is clearI would like to be the first to congratulate you on the least dumb post I've read of yours. Redundant yes, repetitive yes but not stupid. 

Everyone does, to my understanding, think that missteps have been made along the way. You again forget that once a course has started it can take years to find out that you got something wrong! Even the smallest misstep can send you back 4 years. It's science, it tends to work that way. This is is the same for the 1000s of other science based companies across the world. There isn't a special sauce until there is. 

Whats amazing is that you think you know better than our board of directors and advisors. You absolutely do not. You don't think they are acutely aware of the patent expiry? Your arrogance is stunning and based on patently miniscule understanding of biotech. 

You're a zilch and you don't own stock here. It's the same old recycled Fud that you peddle on a weekly basis against a stock you own?! Have some humility and either allow the people who know more than you to do the job or sell up and go back to grafting out pennies. Please, I'm trying to help you, stop convincing yourself you know what you're doing. 
<< Previous
Bullboard Posts
Next >>